Breaking News: Moderna and the U.S. are in a patent dispute over the company's Covid vaccine, with potential consequences for future distribution and profits.

Facebook Twitter RSS Google

Home » Unlabelled » Breaking News: Moderna and the U.S. are in a patent dispute over the company's Covid vaccine, with potential consequences for future distribution and profits.

Breaking News: Moderna and the U.S. are in a patent dispute over the company's Covid vaccine, with potential consequences for future distribution and profits.

BREAKING NEWS

Moderna and the U.S. are in a patent dispute over the company's Covid vaccine, with potential consequences for future distribution and profits.

Tuesday, November 9, 2021 2:43 PM EST

The vaccine grew out of a four-year collaboration between Moderna and the N.I.H., the government's biomedical research agency.

But the company's patent application names several employees as the sole inventors of a crucial component of its coronavirus vaccine, excluding three government scientists.

Read the latest

You received this email because you signed up for NYTimes.com's Breaking News Alerts. To stop receiving these emails, unsubscribe or manage your email preferences.

Subscribe to the Times Get the NYT app

Change Your Email Privacy Policy Contact Advertise California Notice

The New York Times Company, 620 Eighth Avenue, New York, NY 10018

HOT AIR BALLOON FLIGHT

Breaking News: Moderna and the U.S. are in a patent dispute over the company's Covid vaccine, with potential consequences for future distribution and profits.

Moderna and the U.S. are in a patent dispute over the company's Covid vaccine, with potential consequences for future distribution and profits.

Related Post:

Popular Posts

Category